The UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved US pharma major Eli Lilly’s Kisunla (donanemab ...

Swiss pharma giant Roche this morning reported that, in the first nine months of 2024 group sales increased by 6% at CER (2% ...

US clinical-stage biotech AvenCell Therapeutics announced that it has raised $112 million in Series B financing, which was ...

Shares in Sangamo Therapeutics (Nasdaq: SGMO) surged around 40% on Tuesday, following the announcement that the US Food and ...

The US Department of Health and Human Services (HHS), through the Office of Assistant Secretary for Planning and Evaluation ...

The US Food and Drug Administration (FDA) yesterday approved Abrysvo (respiratory syncytial virus vaccine). Developed and ...

GLP-1 therapies are expanding beyond obesity treatment, with research exploring their potential for conditions like liver ...

Shares of Swedish drugmaker Camurus fell almost 10% to 588.50 kroner yesterday after it revealed that the US Food and Drug ...

South Korean firm SK bioscience announced that Indonesia’s Food and Drug Agency, BPOM (Badan Pengawas Obat dan Makanan), has ...

Editas Medicine (Nasdaq: EDIT) has announced plans to seek a partner or buyer for its lead CRISPR program, reni-cel, as the ...

France-based clinical-stage biotech Duhn Therapeutics (which is co-founded by Landmark BioVentures) and Swiss firm OM Pharma ...

UCB today announced that the company has regained all global rights to bepranemab following termination of a collaboration ...